News Feed

Pharmaceutical giant Pfizer has announced promising results from a Phase 3 clinical trial for its new oncology drug targeting rare forms of lung cancer.

Johnson & Johnson is facing a new round of lawsuits related to product safety concerns, potentially impacting the company's financial outlook for the coming year.

Merck has announced a significant investment to expand its manufacturing capabilities in Singapore, aiming to meet growing demand in Asian markets.

Generic drug manufacturers have filed a legal challenge against AbbVie's patent extension for its blockbuster immunology drug, potentially opening the door to earlier generic competition.

Bristol Myers Squibb has announced a strategic partnership with an AI startup to accelerate drug discovery using machine learning algorithms.

Novartis has received FDA approval for its new treatment targeting a rare genetic disorder, expanding the company's portfolio of specialty medications.

Roche has reported better-than-expected first-quarter earnings and raised its full-year guidance, citing strong demand for its diagnostic tests and cancer treatments.

GlaxoSmithKline's experimental vaccine has shown promising results in early-stage trials against an emerging viral threat, potentially positioning the company as a leader in this therapeutic area.

AstraZeneca is experiencing significant supply chain disruptions affecting the distribution of several key products, potentially impacting quarterly sales targets.

Sanofi has announced a comprehensive restructuring plan aimed at streamlining operations and focusing resources on high-growth therapeutic areas.